Position in VTRS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$15,778,977
+$1,327,964 QoQ
Shares Held
1,167,948
+0.6% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Woodline Partners LP holds $139,051,923 across 13 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (11.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,163,863 | $35,055,553 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
448,996 | $23,208,603 | |
| 3 | ALKS |
Alkermes plc.
|
558,567 | $19,750,929 | |
| 4 | PBH |
Prestige Consumer Healthcare Inc.
|
273,943 | $16,236,601 | |
| 5 | VTRS |
Viatris Inc
This page
|
1,167,948 | $15,778,977 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
845,800 | $11,756,620 | |
| 7 | ETON |
Eton Pharmaceuticals, Inc.
|
170,699 | $4,212,851 | |
| 8 | LQDA |
Liquidia Corp
|
100,160 | $3,780,038 |
All Filings in VTRS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,778,977 | 1,167,948 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $14,451,013 | 1,160,724 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $11,339,103 | 1,145,364 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,282,207 | 1,151,423 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $9,970,694 | 1,144,741 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $14,510,997 | 1,165,542 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $10,372,536 | 893,414 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,455,385 | 889,500 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $10,620,630 | 889,500 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $24,834,229 | 2,293,096 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,766,654 | 889,113 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,108,750 | 812,500 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $22,217,249 | 1,996,159 | Shares | Sole | 2023-02-14 | |
| 2022-03-31 | $3,769,920 | 346,500 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,688,145 | 346,500 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,695,075 | 346,500 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,951,485 | 346,500 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $24,188,286 | 1,731,445 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $6,488,312 | 346,228 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||